Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Pain D010146 64 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Weight Gain D015430 101 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Urinary Bladder Diseases D001745 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Neuroblastoma D009447 66 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Nervous System Diseases D009422 37 associated lipids
Ataxia D001259 20 associated lipids
Brain Edema D001929 20 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Brain Ischemia D002545 89 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Substance-Related Disorders D019966 2 associated lipids
Hepatitis D006505 11 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Kukushkin ML et al. Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome. 2006 Bull. Exp. Biol. Med. pmid:17369898
Szabo B et al. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. 2006 J. Physiol. (Lond.) pmid:16973696
Wiley JL et al. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. 2006 Life Sci. pmid:16978656
Thors L and Fowler CJ Is there a temperature-dependent uptake of anandamide into cells? 2006 Br. J. Pharmacol. pmid:16865094
Nilsson O et al. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells. 2006 Eur. J. Pharmacol. pmid:16928371
Schuel H Tuning the oviduct to the anandamide tone. 2006 J. Clin. Invest. pmid:16886056
Kasai HF et al. Studies on high-energy collision-induced dissociation of endogenous cannabinoids: 2-arachidonoylglycerol and n-arachidonoylethanolamide in FAB-mass spectrometry. 2006 Anal Sci pmid:16837740
Murillo-Rodríguez E et al. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. 2006 FEBS Lett. pmid:16844117
Liu J et al. A biosynthetic pathway for anandamide. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16938887
Mechoulam R et al. Endocannabinoids, feeding and suckling--from our perspective. 2006 Int J Obes (Lond) pmid:16570101
Matias I et al. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. 2006 Int J Obes (Lond) pmid:16570107
Schiano Moriello A et al. Development of the first potential covalent inhibitors of anandamide cellular uptake. 2006 J. Med. Chem. pmid:16570928
Kudo R and Hatake K [Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation]. 2006 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:17313058
Appendino G et al. Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. 2006 J. Med. Chem. pmid:16570929
Chang L et al. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. 2006 Br. J. Pharmacol. pmid:16501580
Guagnini F et al. Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. 2006 Gut pmid:16423891
Meuth SG et al. The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. 2006 Mol. Pharmacol. pmid:16424077
Marx J Drug development. Drugs inspired by a drug. 2006 Science pmid:16424309
Cupini LM et al. Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. 2006 Cephalalgia pmid:16472333
García Mdel C et al. Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. 2006 Eur. J. Pharmacol. pmid:16472800
Romano MR and Lograno MD Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. 2006 Br. J. Pharmacol. pmid:16474412
Tuccinardi T et al. Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis. 2006 J. Med. Chem. pmid:16451064
Monterrubio S and Solowij N Chronic stress and adaptation. 2006 Am J Psychiatry pmid:16513893
Bari M et al. New insights into endocannabinoid degradation and its therapeutic potential. 2006 Mini Rev Med Chem pmid:16515464
Overton HA et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. 2006 Cell Metab. pmid:16517404
Matias I et al. Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. 2006 Prostaglandins Leukot. Essent. Fatty Acids pmid:17011761
Bari M et al. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. 2006 J. Immunol. pmid:17015679
Tan B et al. Targeted lipidomics: discovery of new fatty acyl amides. 2006 AAPS J pmid:17025263
Guindon J et al. Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? 2006 Eur. J. Pharmacol. pmid:17027744
Prestifilippo JP et al. Inhibition of salivary secretion by activation of cannabinoid receptors. 2006 Exp. Biol. Med. (Maywood) pmid:16946411
Spoto B et al. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. 2006 Biochimie pmid:16949718
Vlachou S et al. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. 2006 Psychopharmacology (Berl.) pmid:16953388
Mulder AM and Cravatt BF Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines. 2006 Biochemistry pmid:16981687
De Lago E et al. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations. 2006 J. Neurochem. pmid:16899063
Laezza C et al. Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 2006 FEBS Lett. pmid:17055492
Gough NR Focus issue: signaling lipids. 2006 Sci. STKE pmid:16467192
Migliarini B et al. Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics. 2006 FEBS Lett. pmid:16519888
Wang J et al. Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family. 2006 J. Biol. Chem. pmid:16527816
Bortolato M et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. 2006 Neuropsychopharmacology pmid:16541083
Maccarrone M et al. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells. 2006 Thromb. Haemost. pmid:16543970
Siegmund SV et al. Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. 2006 J. Biol. Chem. pmid:16418162
Salo OM et al. 3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. 2006 J. Med. Chem. pmid:16420041
Kohro S et al. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. 2006 J Anesth pmid:16421670
Rawls SM et al. Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats. 2006 Pharmacol. Biochem. Behav. pmid:16647109
Parkkari T et al. Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide. 2006 Bioorg. Med. Chem. pmid:16644227
McFarland MJ et al. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide. 2006 AAPS J pmid:16584138
Varvel SA et al. Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task. 2006 J. Pharmacol. Exp. Ther. pmid:16352706
Giuliano M et al. Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. 2006 Int. J. Mol. Med. pmid:16596265
Di Marzo M et al. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics. 2006 J. Pept. Sci. pmid:16534762
Cobellis G et al. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. 2006 Biol. Reprod. pmid:16611862
Solinas M et al. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. 2006 J. Neurochem. pmid:16805835
Wei BQ et al. A second fatty acid amide hydrolase with variable distribution among placental mammals. 2006 J. Biol. Chem. pmid:17015445
Rösch S et al. R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. 2006 J. Pharmacol. Exp. Ther. pmid:16330497
Zaniewska M et al. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. 2006 Eur. J. Pharmacol. pmid:16730696
Harada N et al. Antithrombin reduces endotoxin-induced hypotension by enhancing pulmonary sensory neuron activation in rats. 2006 Thromb. Haemost. pmid:16732381
van der Stelt M et al. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. 2006 Cell. Mol. Life Sci. pmid:16732431
Sade H et al. Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids. 2006 Am. J. Physiol., Cell Physiol. pmid:16107501
Fisyunov A et al. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. 2006 J. Neurophysiol. pmid:16738209
Vogeser M et al. Release of anandamide from blood cells. 2006 Clin. Chem. Lab. Med. pmid:16599845
Kopczyńska B and Szereda-Przestaszewska M Supranodose vagotomy eliminates anandamide-evoked cardiorespiratory depression in anaesthetized rats. 2006 Respir Physiol Neurobiol pmid:16144778
Wang H et al. Fatty acid amide hydrolase deficiency limits early pregnancy events. 2006 J. Clin. Invest. pmid:16886060
Tzavara ET et al. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. 2006 Biol. Psychiatry pmid:16199010
Schmidt A et al. Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. 2006 Biomed. Chromatogr. pmid:16189813
Wiles AL et al. N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. 2006 J. Neurochem. pmid:16899062
Juan-Picó P et al. Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. 2006 Cell Calcium pmid:16321437
Cannizzaro C et al. Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. 2006 Neurochem. Int. pmid:16325966
Lizanecz E et al. Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. 2006 Mol. Pharmacol. pmid:16338989
Moezi L et al. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. 2006 Br. J. Pharmacol. pmid:17043671
Grimaldi C et al. Anandamide inhibits adhesion and migration of breast cancer cells. 2006 Exp. Cell Res. pmid:16343481
Eljaschewitsch E et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. 2006 Neuron pmid:16387640
de Lago E et al. UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. 2006 Eur Neuropsychopharmacol pmid:16006105
Yang YY et al. Roles of anandamide in the hepatic microcirculation in cirrhotic rats. 2006 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:16407591
Glaser ST et al. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. 2006 J. Pharmacol. Exp. Ther. pmid:16278311
Appendino G et al. First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands. 2006 FEBS Lett. pmid:16406364
Glaser ST et al. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. 2005 Nov-Dec Vis. Neurosci. pmid:16469181
Abalo R et al. Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. 2005 Jul 22-29 Neurosci. Lett. pmid:15936532
Kurabayashi M et al. 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. 2005 Jan-Feb J Invest Surg pmid:15804949
Basavarajappa BS and Hungund BL Role of the endocannabinoid system in the development of tolerance to alcohol. 2005 Jan-Feb Alcohol Alcohol. pmid:15550443
Rodríguez de Fonseca F et al. The endocannabinoid system: physiology and pharmacology. 2005 Jan-Feb Alcohol Alcohol. pmid:15550444
Price TJ et al. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. 2005 Neuropharmacology pmid:15992578
Taddei S Evolving the concept of regulation of vascular tone in humans. 2005 Br. J. Pharmacol. pmid:15997231
Hohmann AG et al. An endocannabinoid mechanism for stress-induced analgesia. 2005 Nature pmid:15973410
Glaser ST et al. Anandamide transport: a critical review. 2005 Life Sci. pmid:15979096
Ambrosi S et al. On the importance of anandamide structural features for its interactions with DPPC bilayers: effects on PLA2 activity. 2005 J. Lipid Res. pmid:15961786
Tian X et al. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. 2005 J. Biol. Chem. pmid:15964843
Wiley JL et al. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. 2005 Eur. J. Pharmacol. pmid:15740725
Matsuda K et al. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. 2005 Tohoku J. Exp. Med. pmid:16141678
Suplita RL et al. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. 2005 Neuropharmacology pmid:16129456
Osei-Hyiaman D et al. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. 2005 Neuroendocrinology pmid:16131814
Mechoulam R and Deutsch DG Toward an anandamide transporter. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16314567
Ligresti A et al. Endocannabinoid metabolic pathways and enzymes. 2005 Curr Drug Targets CNS Neurol Disord pmid:16375679
Flygare J et al. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. 2005 FEBS Lett. pmid:16337199
Sarnataro D et al. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 2005 FEBS Lett. pmid:16263116
Van Sickle MD et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. 2005 Science pmid:16224028
Besana A et al. Lipids and two-pore domain K+ channels in excitable cells. 2005 Prostaglandins Other Lipid Mediat. pmid:16099395
van der Stelt M and Di Marzo V Anandamide as an intracellular messenger regulating ion channel activity. 2005 Prostaglandins Other Lipid Mediat. pmid:16099396
Patsos HA et al. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. 2005 Gut pmid:16099783
Yoshihara S et al. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. 2005 Int. Arch. Allergy Immunol. pmid:16103691
van der Stelt M et al. Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. 2005 EMBO J. pmid:16107881
Lynch DL and Reggio PH Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics. 2005 J. Med. Chem. pmid:16033262